drugset

drugset / Trial / NCT00267670

Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH

NCT00267670 ↗

Phase 2/3 Completed 26 enrolled Northwestern University

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to explore the potential benefit of the medication, pentoxifylline, for the treatment of NASH.

Timeline

Start: 2005-03
Primary completion: 2009-09
Completion: 2009-09

Publications

Van Wagner LB, Koppe SW, Brunt EM, Gottstein J, Gardikiotes K, Green RM, Rinella ME. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. Ann Hepatol. 2011 Jul-Sep;10(3):277-86.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pentoxifylline	Small molecule	400 mg	Oral

Indications